Replies to post #10178 on Inergetics Inc (fka NRTI)

[senor_c]

Start with a company press release and then research from there to make your own conclusions. Not that hard.


http://www.prnewswire.com/news-releases/inergetics-appoints-justin-fischedick-md-to-complete-its-scientificmedical-advisory-board-for-the-development-of-cbd-based-nutritional-supplements-254535981.html


NEWARK, N.J., April 9, 2014 /PRNewswire/ -- Inergetics, Inc. (OTCBB: NRTI), a leading developer of nutritional supplements, today announced the company has completed the formation of its Scientific/Medical Advisory Board with the appointment of Justin Fischedick, M.D. The board is responsible for guiding the formulation of the proprietary line of natural Cannabidiol (CBD)-based nutritional supplements it is developing in partnership with Terra Tech Corp (OCTBB: TRTC).

Dr. Fischedick is a respected expert in the therapeutic and medicinal properties of chemical components of plants, specifically Cannabis. He brings years of experience in advanced chromatography and spectrometry, including proven abilities in the isolation of natural products for scientific and medical analysis.

Dr. Fischedick is currently a Postdoctoral Research Associate at the Institute of Biological Chemistry at Washington State University, and has authored or co-authored several scientific articles on Cannabis, cannabinoids and terpenoids published in top scientific and medical journals. He has presented his scientific research at a number of national and international conferences including the Phytochemical Society of North America conference, the International Conference on Natural Products Research and the International Association for Cannabinoids as Medicine (IACM) conference.

Dr. Fischedick's appointment completes the membership of the Scientific/Medical Advisory Board that Inergetics and Terra Tech has formed to help guide the creation of new CBD-based nutritional supplement products. The board will work with Inergetics' Chief Science Officer, Carl Germano, RD, CNS, CDN, to ensure the quality and efficacy of the new product line.

"Justin is a well-respected leader in researching the medical applications of Cannabis. His understanding of Cannabis and cannabinoids at a molecular level will help ensure that our natural CBD-based nutritional supplements offer effective relief to patients experiencing pain, nausea and other debilitative symptoms," said Carl Germano. "With Justin's appointment, we have assembled an advisory board of the highest caliber with an impressive array of medical and scientific qualifications."

Dr. Fischedick is a member of the Phytochemical Society of North America, the Society for Medicinal Plant and Natural Products Research and the Central New York Mycological Society. He earned his B.S. in Biology from the State University of New York College of Environmental Science and Forestry (SUNY-ESF), and his M.Sc. and Ph.D. in Biology with a focus on Natural Products from the Leiden University, Institute of Biology in The Netherlands.

The strategic partnership between Inergetics and Terra Tech was announced on February 4th and the companies' first CBD-based supplements are expected to be distributed via medicinal marijuana dispensaries.

[senor_c]

Hell, his CV lists his publications. They seem quite relevant and impressive, considering the topic.

[crookedneck]

I will only reiterate what senor already posted about Dr. Fischedick's credentials, which make him one of the many experts in this field. If it is your assumption that he can't be considered an expert due to the simple reason he was a student doing advance research and studies in the marijuana field, you would be making a huge mistake. If anything, it makes him even more qualified as an expert, since he has the most updated and recent research in this field. His accomplishments include various articles that relate directly to this area NRTI is pursuing, so yes I do consider him an Expert and so does his peers! Cheers!

NEWARK, N.J., April 9, 2014 /PRNewswire/ -- Inergetics, Inc. (OTCBB: NRTI), a leading developer of nutritional supplements, today announced the company has completed the formation of its Scientific/Medical Advisory Board with the appointment of Justin Fischedick, M.D. The board is responsible for guiding the formulation of the proprietary line of natural Cannabidiol (CBD)-based nutritional supplements it is developing in partnership with Terra Tech Corp (OCTBB: TRTC).

Dr. Fischedick is a respected expert in the therapeutic and medicinal properties of chemical components of plants, specifically Cannabis. He brings years of experience in advanced chromatography and spectrometry, including proven abilities in the isolation of natural products for scientific and medical analysis.

Dr. Fischedick is currently a Postdoctoral Research Associate at the Institute of Biological Chemistry at Washington State University, and has authored or co-authored several scientific articles on Cannabis, cannabinoids and terpenoids published in top scientific and medical journals. He has presented his scientific research at a number of national and international conferences including the Phytochemical Society of North America conference, the International Conference on Natural Products Research and the International Association for Cannabinoids as Medicine (IACM) conference.

Dr. Fischedick's appointment completes the membership of the Scientific/Medical Advisory Board that Inergetics and Terra Tech has formed to help guide the creation of new CBD-based nutritional supplement products. The board will work with Inergetics' Chief Science Officer, Carl Germano, RD, CNS, CDN, to ensure the quality and efficacy of the new product line.

"Justin is a well-respected leader in researching the medical applications of Cannabis. His understanding of Cannabis and cannabinoids at a molecular level will help ensure that our natural CBD-based nutritional supplements offer effective relief to patients experiencing pain, nausea and other debilitative symptoms," said Carl Germano. "With Justin's appointment, we have assembled an advisory board of the highest caliber with an impressive array of medical and scientific qualifications."

Dr. Fischedick is a member of the Phytochemical Society of North America, the Society for Medicinal Plant and Natural Products Research and the Central New York Mycological Society. He earned his B.S. in Biology from the State University of New York College of Environmental Science and Forestry (SUNY-ESF), and his M.Sc. and Ph.D. in Biology with a focus on Natural Products from the Leiden University, Institute of Biology in The Netherlands.